Suppr超能文献

朊蛋白密码子 129 多态性改变了 C.709-1G>A 颗粒蛋白基因突变所致额颞叶痴呆的发病年龄。

Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation.

机构信息

Department of Neurology, Hospital Donostia, San Sebastian, Gipuzkoa, Spain.

出版信息

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):93-5. doi: 10.1097/WAD.0b013e3181eff695.

Abstract

Frontotemporal lobar degeneration because of mutations in the progranulin (PGRN) gene presents a high variability both in the clinical phenotype and age of onset of disease. Factors that influence this variability remain largely unknown. The aim of our study was to determine whether selected genetic variables modify age at onset of disease in our series of 21 patients with a single splicing mutation (c.709-1G>A) in the PGRN gene, all of whom were of Basque descent. In our analysis, we included the following genetic variables: PGRN rs5848 and rs9897526 polymorphisms, APOE and microtubule-associated protein tau genotypes, and PRNP codon 129 polymorphism. We found no association between PGRN polymorphisms, APOE and microtubule-associated protein tau genotypes, and age at onset of the disease; whereas we report evidence for an association between PRNP codon 129 polymorphism and age at onset of disease in frontotemporal dementia-PGRN(+) patients. MM homozygous carriers presented onset of disease on average 8.5 years earlier than patients who carried at least 1 valine on their PRNP codon 129 (MV or VV). The biological justification for this association remains speculative.

摘要

由于颗粒体蛋白基因(PGRN)突变引起的额颞叶变性在临床表型和疾病发病年龄方面存在高度变异性。影响这种变异性的因素在很大程度上仍然未知。我们的研究目的是确定在我们的 21 名具有 PGRN 基因单一剪接突变(c.709-1G>A)的患者系列中,是否有选定的遗传变量会改变疾病的发病年龄,所有这些患者均为巴斯克血统。在我们的分析中,我们包括了以下遗传变量:PGRN rs5848 和 rs9897526 多态性、APOE 和微管相关蛋白 tau 基因型以及 PRNP 密码子 129 多态性。我们发现 PGRN 多态性、APOE 和微管相关蛋白 tau 基因型与疾病发病年龄之间没有关联;而我们报告了 PRNP 密码子 129 多态性与额颞叶痴呆-PGRN(+)患者发病年龄之间存在关联的证据。MM 纯合子携带者的发病年龄平均比 PRNP 密码子 129 上至少携带 1 个缬氨酸的患者(MV 或 VV)早 8.5 年。这种关联的生物学依据仍在推测之中。

相似文献

1
Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation.
Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):93-5. doi: 10.1097/WAD.0b013e3181eff695.
4
rs5848 polymorphism and serum progranulin level.
J Neurol Sci. 2011 Jan 15;300(1-2):28-32. doi: 10.1016/j.jns.2010.10.009. Epub 2010 Nov 2.
5
Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia.
Neurobiol Aging. 2009 Nov;30(11):1825-33. doi: 10.1016/j.neurobiolaging.2008.01.005. Epub 2008 Mar 7.
6
"Frontotemporoparietal" dementia: clinical phenotype associated with the c.709-1G>A PGRN mutation.
Neurology. 2009 Oct 27;73(17):1367-74. doi: 10.1212/WNL.0b013e3181bd82a7.
7
Neuropsychological features of asymptomatic c.709-1G>A progranulin mutation carriers.
J Int Neuropsychol Soc. 2012 Nov;18(6):1086-90. doi: 10.1017/S1355617712000823.
8
Prominent phenotypic variability associated with mutations in Progranulin.
Neurobiol Aging. 2009 May;30(5):739-51. doi: 10.1016/j.neurobiolaging.2007.08.022. Epub 2007 Oct 18.
10
Frequency of progranulin mutations in a German cohort of 79 frontotemporal dementia patients.
J Neurol. 2009 Dec;256(12):2043-51. doi: 10.1007/s00415-009-5248-6. Epub 2009 Jul 19.

引用本文的文献

2
Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge.
Alzheimers Res Ther. 2022 Jun 29;14(1):90. doi: 10.1186/s13195-022-01033-4.
3
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
Lancet Neurol. 2020 Feb;19(2):145-156. doi: 10.1016/S1474-4422(19)30394-1. Epub 2019 Dec 3.
5
Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene.
Mol Neurodegener. 2014 Sep 20;9:38. doi: 10.1186/1750-1326-9-38.

本文引用的文献

1
"Frontotemporoparietal" dementia: clinical phenotype associated with the c.709-1G>A PGRN mutation.
Neurology. 2009 Oct 27;73(17):1367-74. doi: 10.1212/WNL.0b013e3181bd82a7.
2
Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
Neurobiol Dis. 2009 Mar;33(3):379-85. doi: 10.1016/j.nbd.2008.11.008. Epub 2008 Dec 6.
3
Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.
Neuropathol Appl Neurobiol. 2008 Aug;34(4):446-56. doi: 10.1111/j.1365-2990.2008.00963.x.
5
Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.
Biol Psychiatry. 2008 May 15;63(10):946-52. doi: 10.1016/j.biopsych.2007.08.015. Epub 2007 Oct 22.
7
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.
Hum Mol Genet. 2006 Oct 15;15(20):2988-3001. doi: 10.1093/hmg/ddl241. Epub 2006 Sep 1.
8
Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.
Neurosci Lett. 2006 Oct 9;406(3):235-9. doi: 10.1016/j.neulet.2006.07.037. Epub 2006 Aug 14.
9
The prion protein in human neurodegenerative disorders.
Neurosci Lett. 2002 Sep 6;329(3):269-72. doi: 10.1016/s0304-3940(02)00668-7.
10
Association of an extended haplotype in the tau gene with progressive supranuclear palsy.
Hum Mol Genet. 1999 Apr;8(4):711-5. doi: 10.1093/hmg/8.4.711.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验